Skip to content
NoticeEducational reference onlyLearn more

Source text

"Pharmacopoeia of the People's Republic of China"

《中华人民共和国药典》

Modern · 1953

国家药典委员会 (Pharmacopoeia Commission of the PRC)

Modern textbook

Last reviewed: July 3, 2026

Introduction

"Pharmacopoeia of the People's Republic of China"

This page is cultural documentation, not medical advice.

The official national drug standard of the People's Republic of China, first published in 1953 and revised approximately every five years. The 2020 edition (current) is the statutory basis for 中成药 quality, identification, assay, and "functional indication" (功能主治) of every officially listed formula.

Compiled by the Pharmacopoeia Commission of the PRC (国家药典委员会) under the National Medical Products Administration (NMPA), the Pharmacopoeia has been revised approximately every five years since 1953. The 2020 edition (一部) lists hundreds of Chinese-medicine 中成药 with monographs specifying formula composition, quality markers, dosage forms, and the official "functional indication" (功能主治) used on labels and clinical guidance. For modern formulas that have no classical source text (such as modern 中成药 developed in the 1950s-1970s), the Pharmacopoeia monograph is the primary editorial source for both the formula and its "功能主治" statement.

Historical background

The Pharmacopoeia of the People's Republic of China (中华人民共和国药典) was first published in 1953, soon after the founding of the PRC, as the state's first unified national drug standard. The text is compiled by the Pharmacopoeia Commission of the PRC (国家药典委员会) under the National Medical Products Administration (NMPA), drawing on a panel of experts from Chinese medicine, Western medicine, and pharmaceutical sciences. Since 1953 the Pharmacopoeia has been revised approximately every five years (1953, 1963, 1977, 1985, 1990, 1995, 2000, 2005, 2010, 2015, 2020), with each edition issuing statutory monographs for raw materials, processed slices, and 中成药 preparations. From the 2005 edition onward the work has been published in a divided structure (一部, 二部, 三部) by category of drug.…

View in glossary

About the author

国家药典委员会 (Pharmacopoeia Commission of the PRC)

The Pharmacopoeia Commission of the PRC (国家药典委员会) is the national standards body responsible for compiling the Pharmacopoeia, operating under the National Medical Products Administration (NMPA).…

Formulas recorded in this text· 5

  • Formula · Chuān Bèi Pí Pá Gāo

    Chuanbei Loquat Syrup

    川贝枇杷膏

    A flagship "runfei zhi-ke" loquat-and-fritillaria syrup from the 1956 Pharmacopoeia, the more "classical" sibling of the modern honey-refined Strong Loquat Syrup.

  • Formula · Qiáng Lì Pí Pá Gāo

    Strong Loquat Syrup

    强力枇杷膏(蜜炼)

    A honey-refined "runfei zhi-ke" (moisten the lung and stop cough) syrup from the 1969 Pharmacopoeia, widely sold over the counter in Chinese pharmacies for dry, tickling cough.

  • Formula · Ān Shén Bǔ Xīn Wán

    Calm-Spirit Heart-Tonifying

    安神补心丸

    A modern "yang-xin an-shen" (nourish the heart and calm the spirit) formula standardized in the 1977 Pharmacopoeia, the most widely sold TCM "insomnia + heart-flutter" formula in mainland China.

  • Formula · Huáng Lián Sù Piàn

    Berberine Tablets

    黄连素片

    A modern "qing-re zao-shi" (clear heat and dry dampness) single-component preparation from the 1977 Pharmacopoeia, essentially the isolated alkaloid berberine HCl extracted from Coptis (huanglian).

Concerns covered in this text· 4